Engineering a 3D functional human peripheral nerve in vitro using the Nerve-on-a-Chip platform

Development of “organ-on-a-chip” systems for neuroscience applications are lagging due in part to the structural complexity of the nervous system and limited access of human neuronal & glial cells. In addition, rates for animal models in translating to human success are significantly lower for neurodegenerative diseases. Thus, a preclinical in vitro human cell-based model capable of providing critical clinical metrics such as nerve conduction velocity and histomorphometry are necessary to improve prediction and translation of in vitro data to successful clinical trials. To answer this challenge, we present an in vitro biomimetic model of all-human peripheral nerve tissue capable of showing robust neurite outgrowth (~5 mm), myelination of hNs by primary human Schwann cells (~5%), and evaluation of nerve conduction velocity (0.13–0.28 m/sec), previously unrealized for any human cell-based in vitro system. To the best of our knowledge, this Human Nerve-on-a-chip (HNoaC) system is the first biomimetic microphysiological system of myelinated human peripheral nerve which can be used for evaluating electrophysiological and histological metrics, the gold-standard assessment techniques previously only possible with in vivo studies.

[1]  M. J. Moore,et al.  Microengineered peripheral nerve-on-a-chip for preclinical physiological testing. , 2015, Lab on a chip.

[2]  A. Kamath,et al.  Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic. , 2016, Regulatory toxicology and pharmacology : RTP.

[3]  N. Kleitman,et al.  Human Schwann cells in vitro. II. Myelination of sensory axons following extensive purification and heregulin-induced expansion. , 1995, Journal of neurobiology.

[4]  V. Flacher,et al.  Development of an innervated tissue-engineered skin with human sensory neurons and Schwann cells differentiated from iPS cells. , 2018, Acta biomaterialia.

[5]  YongTae Kim,et al.  Organs-on-Chips , 2019, Encyclopedia of Biomedical Engineering.

[6]  D. Geschwind,et al.  Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture , 2015, Nature Methods.

[7]  S. Palve,et al.  Impact of Aging on Nerve Conduction Velocities and Late Responses in Healthy Individuals , 2018, Journal of Neurosciences in Rural Practice.

[8]  E. Shooter,et al.  NGF Controls Axonal Receptivity to Myelination by Schwann Cells or Oligodendrocytes , 2004, Neuron.

[9]  S. Hyman,et al.  Improving and Accelerating Drug Development for Nervous System Disorders , 2014, Neuron.

[10]  N. Ratner,et al.  Axons arrest the migration of Schwann cell precursors. , 1994, Development.

[11]  Donald E Ingber,et al.  Microengineered physiological biomimicry: organs-on-chips. , 2012, Lab on a chip.

[12]  M. Hadjiargyrou,et al.  CD9 plays a role in Schwann cell migration in vitro , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[14]  Andreas Hierlemann,et al.  Recording Large Extracellular Spikes in Microchannels along Many Axonal Sites from Individual Neurons , 2015, PloS one.

[15]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[16]  Kenta Shimba,et al.  A co-culture microtunnel technique demonstrating a significant contribution of unmyelinated Schwann cells to the acceleration of axonal conduction in Schwann cell-regulated peripheral nerve development. , 2017, Integrative biology : quantitative biosciences from nano to macro.

[17]  M. Fontès,et al.  Ascorbic acid, myelination and associated disorders , 2013 .

[18]  Jianrong Li,et al.  Preparation of Rat Brain Aggregate Cultures for Neuron and Glia Development Studies , 2009, Journal of visualized experiments : JoVE.

[19]  A. Höke,et al.  Human Schwann cells retain essential phenotype characteristics after immortalization. , 2012, Stem cells and development.

[20]  Jewel L. Podratz,et al.  Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro , 2004, Glia.

[21]  C. Walsh,et al.  What Are Mini-Brains? , 2013, Science.

[22]  T. Gordon,et al.  Effects of short‐ and long‐term Schwann cell denervation on peripheral nerve regeneration, myelination, and size , 2000, Glia.

[23]  A. Windebank,et al.  Myelination determines the caliber of dorsal root ganglion neurons in culture , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  E. Scarpini,et al.  Cultures of human Schwann cells isolated from fetal nerves , 1988, Brain Research.

[25]  J. Salzer Schwann cell myelination. , 2015, Cold Spring Harbor perspectives in biology.

[26]  Michael J Moore,et al.  Methods for fabrication and evaluation of a 3D microengineered model of myelinated peripheral nerve. , 2018, Journal of neural engineering.

[27]  G. Fuller How to get the most out of nerve conduction studies and electromyography , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  Marja Nissinen,et al.  Myelination in mouse dorsal root ganglion/Schwann cell cocultures , 2008, Molecular and Cellular Neuroscience.

[29]  David W Sant,et al.  Phenotypic and Functional Characteristics of Human Schwann Cells as Revealed by Cell-Based Assays and RNA-SEQ , 2018, Molecular Neurobiology.

[30]  A. Weir,et al.  Nerve conduction studies: essentials and pitfalls in practice , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  Diego Ghezzi,et al.  A microfabricated nerve-on-a-chip platform for rapid assessment of neural conduction in explanted peripheral nerve fibers , 2018, Nature Communications.

[32]  Fritz Buchthal,et al.  Evoked action potentials and conduction velocity in human sensory nerves , 1966 .

[33]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[34]  D. Pleasure,et al.  Establishment of Schwann cell cultures from adult rat peripheral nerves , 1988, Experimental Neurology.

[35]  D. Ingber,et al.  From 3D cell culture to organs-on-chips. , 2011, Trends in cell biology.

[36]  M. Pangalos,et al.  Drug development for CNS disorders: strategies for balancing risk and reducing attrition , 2007, Nature Reviews Drug Discovery.

[37]  H. Willison,et al.  Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination , 2017, Brain : a journal of neurology.

[38]  L. Glaser,et al.  Release of autocrine growth factor by primary and immortalized Schwann cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Bunge,et al.  Isolation and functional characterization of Schwann cells derived from adult peripheral nerve , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[41]  M. Wiberg,et al.  Development and validation of an in vitro model system to study peripheral sensory neuron development and injury , 2018, Scientific Reports.

[42]  M. Geyer,et al.  Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets , 2016, Nature Reviews Drug Discovery.

[43]  J. Salzer,et al.  Glial Growth Factor/Neuregulin Inhibits Schwann Cell Myelination and Induces Demyelination , 2001, The Journal of cell biology.